HSD11B1 c.220-208T>G

Variant ID: 1-209879846-T-G

NM_005525.3(HSD11B1):c.220-208T>G

This variant was identified in 3 publications

View GRCh38 version.




Publications:


Use of Protamine in Nanopharmaceuticals-A Review.

Nanomaterials (Basel, Switzerland)
Ruseska, Ivana I; Fresacher, Katja K; Petschacher, Christina C; Zimmer, Andreas A
Publication Date: 2021-06-07

Variant appearance in text: rs12040780
PubMed Link: 34200384
Variant Present in the following documents:
  • Main text
View BVdb publication page



Aptamer-Functionalized Nanoparticles in Targeted Delivery and Cancer Therapy.

International Journal Of Molecular Sciences
Fu, Zhaoying Z; Xiang, Jim J
Publication Date: 2020-11-30

Variant appearance in text: rs12040780
PubMed Link: 33266216
Variant Present in the following documents:
  • Main text
View BVdb publication page



Aptamer-Equipped Protamine Nanomedicine for Precision Lymphoma Therapy.

Cancers
Zeng, Zihua Z; Tung, Ching-Hsuan CH; Zu, Youli Y
Publication Date: 2020-03-25

Variant appearance in text: rs12040780
PubMed Link: 32218299
Variant Present in the following documents:
  • Main text
  • cancers-12-00780.pdf
View BVdb publication page